ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
1.02%
US Tech 100
20,118.40
0.00%
Dow Jones
39,721.36
1.09%
Brent Oil
85.165
0.14%
Bitcoin
58,197.89
0.76%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. GSK plc (GSK)

  7. GSK plc (GSK) News

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
02/01/20219:38AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/27/20217:14AMDow Jones NewsGlaxoSmithKline, Eli Lilly, Vir Partner on Therapy for Moderate Covid-19 CasesNYSE:GSKGSK plc
01/27/20216:45AMGlobeNewswire Inc.Lilly, Vir Biotechnology and GSK Announce First Patient Dosed in Expanded BLAZE-4 Trial Evaluating Bamlanivimab (LY-CoV555) w...NYSE:GSKGSK plc
01/27/20216:45AMPR Newswire (US)Lilly, Vir Biotechnology and GSK announce first patient dosed in expanded BLAZE-4 trial evaluating bamlanivimab (LY-CoV555) w...NYSE:GSKGSK plc
01/26/202112:06PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/26/20219:29AMDow Jones NewsClydesdales Charge Into a Super Bowl Ad After All -- for Sam AdamsNYSE:GSKGSK plc
01/26/20213:45AMDow Jones NewsHikma Pharmaceuticals Says It Is in Talks With GlaxoSmithKline to Buy Some BusinessesNYSE:GSKGSK plc
01/22/20216:25AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/20/202111:27AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/20/202111:15AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/20/202110:52AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/19/20211:47PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/19/20216:46AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/15/202112:53PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/15/202111:43AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/13/202110:06AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/12/20213:00AMGlobeNewswire Inc.Vir Biotechnology and GSK Announce NHS-Supported AGILE Study to Evaluate VIR-7832 in the Early Treatment of COVID-19NYSE:GSKGSK plc
01/11/20217:00AMPR Newswire (US)Eligo inks deal with GSK potentially worth up to $224MNYSE:GSKGSK plc
01/11/20217:00AMPR Newswire (US)Eligo inks deal with GSK potentially worth up to $224MNYSE:GSKGSK plc
01/11/20216:46AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/11/20216:14AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
01/08/20213:07PMDow Jones NewsCorrection to Drugmakers Raise Prices Article of Jan. 1NYSE:GSKGSK plc
01/04/20216:47AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
12/30/20207:41AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
12/23/202011:22AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
12/21/20206:28AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:GSKGSK plc
12/21/20203:00AMDow Jones NewsGlaxoSmithKline Says EU Approves Long-Acting HIV TreatmentNYSE:GSKGSK plc
12/17/20206:30PMDow Jones NewsVir Biotech, GSK Dose Patient in NIH-Sponsored Trial of Covid-19 TreatmentNYSE:GSKGSK plc
12/17/20204:01PMGlobeNewswire Inc.Vir Biotechnology and GSK Announce Start of NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID...NYSE:GSKGSK plc
12/17/20209:57AMDow Jones NewsGlaxoSmithKline's Benlysta Gets FDA Approval for Lupus NephritisNYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK

Your Recent History

USOTC
AABB
Asia Broadband (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
MAXN
Maxeon Solar Technologies
NASDAQ
FCEL
FuelCell Energy
USOTC
RONN
Ronn Motor (PK)
USOTC
RDGL
Vivos (QB)
USOTC
RXMD
Progressive Care (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
AXXA
Exxe (PK)
USOTC
VXIT
Virexit Technologies (PK)
AMEX
SPY
SPDR S&P 500
USOTC
RNVA
Rennova Health (PK)
NASDAQ
AMRN
Amarin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved